Hangyu Liao

407 total citations
9 papers, 297 citations indexed

About

Hangyu Liao is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hangyu Liao has authored 9 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hangyu Liao's work include Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers) and Circular RNAs in diseases (2 papers). Hangyu Liao is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Cancer Cells and Metastasis (3 papers) and Circular RNAs in diseases (2 papers). Hangyu Liao collaborates with scholars based in China. Hangyu Liao's co-authors include Mingxin Pan, Lei Cai, Kunling Chen, Yuan Cheng, Wenbin Huang, Liang Zhao, Yujun Tang, Guolin He, Weimei Huang and Donghui Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Cancers and Frontiers in Oncology.

In The Last Decade

Hangyu Liao

9 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hangyu Liao China 7 166 161 151 99 43 9 297
Jianchang Fu China 9 131 0.8× 143 0.9× 126 0.8× 113 1.1× 106 2.5× 12 325
Guangshun Sun China 6 133 0.8× 160 1.0× 144 1.0× 95 1.0× 96 2.2× 8 306
Aiqing Yang China 5 107 0.6× 175 1.1× 82 0.5× 104 1.1× 118 2.7× 10 315
Chengming Gao China 3 95 0.6× 152 0.9× 74 0.5× 98 1.0× 113 2.6× 5 286
Maria Saigí Spain 10 104 0.6× 203 1.3× 142 0.9× 172 1.7× 66 1.5× 24 380
Shichun Lu China 3 84 0.5× 132 0.8× 74 0.5× 91 0.9× 103 2.4× 6 269
Qiangnu Zhang China 12 217 1.3× 277 1.7× 65 0.4× 50 0.5× 29 0.7× 24 372
Xianguo Zhou China 10 159 1.0× 241 1.5× 93 0.6× 49 0.5× 22 0.5× 22 345
Chengcheng Shi China 8 56 0.3× 168 1.0× 75 0.5× 93 0.9× 24 0.6× 22 261
Mika Chiba Japan 7 75 0.5× 139 0.9× 95 0.6× 120 1.2× 31 0.7× 8 241

Countries citing papers authored by Hangyu Liao

Since Specialization
Citations

This map shows the geographic impact of Hangyu Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hangyu Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hangyu Liao more than expected).

Fields of papers citing papers by Hangyu Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hangyu Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hangyu Liao. The network helps show where Hangyu Liao may publish in the future.

Co-authorship network of co-authors of Hangyu Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Hangyu Liao. A scholar is included among the top collaborators of Hangyu Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hangyu Liao. Hangyu Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liao, Qing, Xin‐Hui Zhou, Ling Wu, et al.. (2025). Gut microbial metabolite 4-hydroxybenzeneacetic acid drives colorectal cancer progression via accumulation of immunosuppressive PMN-MDSCs. Journal of Clinical Investigation. 135(11). 6 indexed citations
2.
Liao, Hangyu, Jun Yang, Yuyan Xu, et al.. (2023). Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation. Cancers. 15(19). 4900–4900. 2 indexed citations
3.
Xu, Yuyan, Jian‐Peng Cai, Lei Cai, et al.. (2023). Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection. Frontiers in Oncology. 13. 1119744–1119744. 13 indexed citations
4.
Guo, Zeyi, Hangyu Liao, Xiaoge Niu, et al.. (2022). A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles. Journal of Tissue Engineering. 13. 1768622397–1768622397. 12 indexed citations
5.
Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations
6.
Huang, Wenbin, Kunling Chen, Donghui Zhang, et al.. (2021). ABCC5 facilitates the acquired resistance of sorafenib through the inhibition of SLC7A11-induced ferroptosis in hepatocellular carcinoma. Neoplasia. 23(12). 1227–1239. 111 indexed citations
7.
Wang, Chunming, Wenbin Huang, Cheng Zhang, et al.. (2021). Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma. Frontiers in Oncology. 11. 686365–686365. 8 indexed citations
8.
Wang, Chunming, Xiaoyu Pu, Lei Cai, et al.. (2020). Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 10. 1758–1758. 37 indexed citations
9.
Tang, Yujun, Yuan Chen, Lei Luo, et al.. (2019). Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1. Journal of Experimental & Clinical Cancer Research. 38(1). 234–234. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026